ADHD Predominantly Inattentive Type: Clinical Trials

2 trials for ADHD Predominantly Inattentive Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow ADHD Predominantly Inattentive Type: new trials by email Literature Review of ADHD Predominantly Inattentive Type trials Research Report on ADHD Predominantly Inattentive Type

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Sertraline, Placebo - Neurodevelopmental Disorders, Autism
Phase 2RecruitingHolland Bloorview Kids Rehabilitation Hospital1302024-09-162026-07-27
Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder
Metadoxine (MG01CI), Placebo - ADHD Predominantly Inattentive Type
Phase 2CompletedAlcobra Ltd.362013-08-012014-01-14

Narrower conditions

Attention Deficit Disorder with Hyperactivity (2)  ·  22q11 Deletion Syndrome (1)  ·  Anxiety Disorders (1)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  DiGeorge Syndrome (1)  ·  Fragile X Syndrome (1)  ·  Neurodevelopmental Disorders (1)  ·  Tic Disorders (1)  ·  Tourette Syndrome (1)  ·  Tuberous Sclerosis (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (2)  ·  Mental Disorders (2)  ·  Abnormalities, Multiple (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Child Development Disorders, Pervasive (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Craniofacial Abnormalities (1)  ·  Endocrine System Diseases (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Selective Serotonin Reuptake Inhibitors (1)  ·  Sertraline (1)  ·  metadoxine (1)

Sponsors

Alcobra Ltd. (1)  ·  Holland Bloorview Kids Rehabilitation Hospital (1)

Countries

Canada (1)  ·  Israel (1)

Top investigators

Dr. Evdokia Anagnostou (1)  ·  Iris Manor, Dr. (1)

Results publications

PMID 25295645